A

R

ANDRÉS , Raquel

Last name: ANDRÉS

First name: Raquel

November 10, 2022 (v1)

Publication

Metadata-only

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study

Cruz Merino, Luis de la Gion, María Cruz Jurado, Josefina

The PANGEA-Breast trial evaluated a new chemo-immunotherapeutic combination that would synergistically induce long-term clinical benefit in HER2-negative advanced breast cancer patients. Treatment consisted of 21-day cycles of 200 mg of pembrolizumab (day 1) plus gemcitabine (days 1 and 8). The primary objective was the objective response rate...

Uploaded on: March 24, 2023